Ziegler R
Department of Internal Medicine I, University of Heidelberg, Germany.
Horm Metab Res Suppl. 1992;26:90-4.
Whether there is a diabetic osteopathy" or osteopathy in diabetes mellitus", is still unclear. Epidemiological studies show in part discrepant results: bone mass was diminished in some studies, unchanged in others--even more positive trends were reported. Increases in osteoporotic fractures were observed in smaller collectives whereas no general trends for fracturing bones were found in diabetics. There are many in part favouring, in part impairing factors to be taken into consideration: Diabetes mellitus type I is a disease including immune phenomena. As inflammation leads to bone loss (inflammation-mediated osteopenia = IMO), peak bone mass may be influenced by such a process. The lack of insulin-like growth factors may be decisive, too. Complications of diabetes mellitus include hypogonadism--this may be disadvantageous for the skeleton. Diabetic complications like retinopathy, neuropathy, and angiopathy may influence the fracture event independently from bone mass. On the other hand, diabetes mellitus type II may be somehow protected against bone loss: Increased adipose tissue in connection with the frequently seen overweight yields metabolically active steroid hormones, insulin related growth factors may stimulate bone formation (e.g. in Forestier's disease). Older diabetics do not show diminished life expectancy any more due to their regular medical care--whether this includes the risk of bone diseases, is not yet clear. It may be worth to further analyse these "positive" effects seen in bones of type II diabetics because they may be useful in osteoporosis even in non-diabetics.
是否存在“糖尿病性骨病”或“糖尿病中的骨病”仍不明确。流行病学研究部分显示出不一致的结果:一些研究中骨量减少,另一些研究中则无变化——甚至有更积极的趋势被报道。在较小的群体中观察到骨质疏松性骨折增加,而在糖尿病患者中未发现骨折的总体趋势。有许多因素,有些起促进作用,有些起损害作用,需要考虑:I型糖尿病是一种包括免疫现象的疾病。由于炎症导致骨质流失(炎症介导的骨质减少=IMO),峰值骨量可能会受到这样一个过程的影响。胰岛素样生长因子的缺乏也可能起决定性作用。糖尿病的并发症包括性腺功能减退——这对骨骼可能不利。糖尿病并发症如视网膜病变、神经病变和血管病变可能独立于骨量影响骨折事件。另一方面,II型糖尿病可能在某种程度上对骨质流失有保护作用:与常见的超重相关的脂肪组织增加会产生具有代谢活性的类固醇激素,胰岛素相关生长因子可能刺激骨形成(如在福里斯特尔病中)。老年糖尿病患者由于定期医疗护理,预期寿命不再缩短——这是否包括骨病风险尚不清楚。进一步分析在II型糖尿病患者骨骼中看到的这些“积极”影响可能是值得的,因为它们甚至在非糖尿病患者的骨质疏松症中也可能有用。